B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0072
Full Text
Open PDFAbstract
Available in full text
Date
April 25, 2011
Authors
Publisher
American Association for Cancer Research (AACR)